MedPath

Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner

Completed
Conditions
Amblyopia
Strabismus
Interventions
Device: Pediatric Vision Scanner
Registration Number
NCT01726842
Lead Sponsor
Rebiscan, Inc.
Brief Summary

The purpose of this project is to compare the performance of the Pediatric Vision Scanner (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at detecting amblyopia and strabismus.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Normal ControlsPediatric Vision ScannerStructurally normal eye with equal visual acuity and normal stereopsis.
Referral requiredPediatric Vision ScannerDiagnosed with amblyopia or constant strabismus, categorized based on the GSE. Amblyopia: * VA \<20/40 and 2 logMAR lines difference in normal eye * Mild amblyopia (\>20/40) * Moderate amblyopia (20/40 and \<20/100) * Severe amblyopia (≥20/100 or worse) * Bilateral amblyopia: \>4 years age VA\<20/40 OU including high hyperopia or high astigmatism. Strabismus: * Constant: \>2 PD at near and or distance. * Intermittent: strabismus that could be controlled intermittently either through fusional mechanisms or a compensatory head position. Amblyogenic factor categorization: * 'Anisometropia'- (1.5 Diopters (D) or more difference in refractive error between the two eyes. * 'hypermetropia' (≥3.5 D), * 'myopia' (≥-4.0 D), * 'astigmatism' (≥1.5 D). * 'structural abnormalities' of the eye will not be excluded, but will be considered to have vision loss if visual acuity is 20/40 or worse.
BorderlinePediatric Vision Scanner(no long-term harm to patient if referral is delayed, however the patient does have conditions that might benefit from monitoring): Equal visual acuity and no structural abnormality with any of the following: Amblyogenic factor, intermittent strabismus, structural abnormalities, refractive error, reduced stereopsis.
Primary Outcome Measures
NameTimeMethod
Binocularity scoreDay 1
Secondary Outcome Measures
NameTimeMethod
Presence of amblyopia risk factorsDay 1

Trial Locations

Locations (1)

Retina Foundation of the Southwest

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath